● Recruiting

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease

Condition: Aortoiliac Occlusive Disease · Sponsor: W.L.Gore & Associates

PhaseN/A

Planned participants158

Who can joinAll sexes, 18 Years to 100 Years

Healthy volunteersNo

About this study

The study will assess the safety and effectiveness of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis ("VBX Device" or also referred to as "VBX Stent Graft") in a post approval setting and evaluate the quality of the use in covered endovascular reconstruction of the aortic bifurcation (CERAB) to treat Aortoiliac Occlusive Disease (AIOD).

This description comes directly from the study's public registry record.

Talk to the study team

Jennifer Camoriano, BS · 14805365820 · jcamoria@wlgore.com

Chris Timberlake, BS · 1-928-707-4974 · ctimberl@wlgore.com

Always discuss trial participation with your own doctor first.

Locations (26)

University of California	Fresno, California, United States	Recruiting
University of South Florida	Tampa, Florida, United States	Recruiting
Mayo Clinic Rochester	Rochester, Minnesota, United States	Recruiting
Cooper University Hospital	Camden, New Jersey, United States	Recruiting
Rutgers	New Brunswick, New Jersey, United States	Recruiting
Research Foundation SUNY Buffalo	Buffalo, New York, United States	Recruiting
Mount Sinai Medical Center	New York, New York, United States	Recruiting
Research Foundation at SUNY Syracuse	Syracuse, New York, United States	Recruiting
Atrium Health Sanger Heart & Vascular Institute	Charlotte, North Carolina, United States	Recruiting
Ohio State University Medical Center	Columbus, Ohio, United States	Recruiting
Geisinger Medical Center	Danville, Pennsylvania, United States	Recruiting
University Of Pennsylvania	Philadelphia, Pennsylvania, United States	Recruiting

+ 14 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06872905